Medulloblastoma: Symptoms, Causes, Diagnosis, Treatment, and Survival Rates 

~Introduction to Medulloblastoma

Medulloblastoma is a fast-growing, malignant brain tumor that primarily develops in the cerebellum—the lower back part of the brain responsible for coordination, balance, and motor control. It is classified as a primitive neuroectodermal tumor (PNET) and is considered one of the most common malignant brain tumors in children.

Although medulloblastoma predominantly affects children between the ages of 3 and 8, it can also occur in adolescents and, rarely, adults. Early diagnosis and advances in multimodal therapy—including surgery, radiation, and chemotherapy—have significantly improved survival rates over the past few decades.

This comprehensive guide provides an in-depth overview of medulloblastoma, covering key aspects such as symptoms, causes, risk factors, molecular subtypes, diagnosis, treatment options, prognosis, survival rates, and long-term outcomes.

~What Is Medulloblastoma?

Medulloblastoma is a Grade 4 tumor according to the World Health Organization (WHO) classification. Grade 4 means the tumor is highly aggressive, grows rapidly, and has the potential to spread (metastasize) to other parts of the brain and spinal cord via cerebrospinal fluid (CSF).

Unlike many adult brain tumors, medulloblastoma often spreads along the spinal cord at the time of diagnosis, making comprehensive evaluation essential.

~How Common Is Medulloblastoma?

• Accounts for approximately 20% of all childhood brain tumors

• Most common malignant brain tumor in children

• Rare in adults (less than 1% of adult brain tumors)

• Slightly more common in males than females

In India and globally, improved neuroimaging and pediatric oncology services have enhanced detection and management outcomes.

~Types and Molecular Subgroups of Medulloblastoma

Modern research has identified four major molecular subgroups, each with distinct genetic characteristics and outcomes:

1. WNT Subgroup

• Best prognosis

• Often occurs in older children

• Survival rate exceeds 90% with treatment

2. SHH (Sonic Hedgehog) Subgroup

• Common in infants and adults

• Intermediate prognosis

• Associated with genetic mutations

3. Group 3

• Most aggressive form

• Higher risk of metastasis

• Lower survival rate

4. Group 4

• Most common subtype

• Intermediate prognosis

• Frequently diagnosed in school-age children

Understanding these subgroups helps doctors tailor treatment and predict outcomes more accurately.

~Causes of Medulloblastoma

The exact cause of medulloblastoma remains unknown. However, it is believed to result from genetic mutations that cause uncontrolled cell growth in cerebellar cells.

Genetic Factors

Certain inherited conditions increase risk:

• Gorlin syndrome

• Turcot syndrome

• Li-Fraumeni syndrome

• Familial adenomatous polyposis (FAP)

Most cases, however, are sporadic, meaning they occur without a clear inherited cause.

~Risk Factors

While medulloblastoma has no well-defined environmental causes, known risk factors include:

• Young age (most common in children under 10)

• Male gender

• Genetic predisposition syndromes

• Prior radiation exposure (rare)

~Symptoms of Medulloblastoma

Symptoms usually develop due to increased intracranial pressure or cerebellar dysfunction.

Early Symptoms

• Persistent morning headaches

• Nausea and vomiting

• Dizziness

• Fatigue

• Irritability in young children

Neurological Symptoms

• Poor balance (ataxia)

• Difficulty walking

• Clumsiness

• Double vision

• Abnormal eye movements

• Slurred speech

Advanced Symptoms

• Back pain (if spread to spinal cord)

• Weakness in limbs

• Behavioral changes

• Enlarged head in infants

Symptoms may worsen rapidly because medulloblastoma grows quickly.

~How Is Medulloblastoma Diagnosed?

Early diagnosis is critical for improving survival outcomes.

1. Neurological Examination

Doctors assess coordination, reflexes, vision, and motor function.

2. MRI Scan

MRI of the brain and spine is the gold standard imaging method. It shows tumor location, size, and possible spread.

3. CT Scan

May be used in emergency situations.

4. Lumbar Puncture (Spinal Tap)

Checks cerebrospinal fluid (CSF) for cancer cells.

5. Biopsy and Surgical Resection

Tumor tissue is examined under a microscope to confirm diagnosis and determine molecular subtype.

~Staging of Medulloblastoma

Staging determines whether the tumor has spread:

• M0 – No metastasis

• M1 – Cancer cells in CSF

• M2 – Spread within brain

• M3 – Spread to spinal cord

• M4 – Spread outside central nervous system (rare)

Risk classification is generally divided into:

• Standard-risk

• High-risk

~Treatment of Medulloblastoma

Treatment typically involves a combination of therapies:

1. Surgery

The first step is maximal safe surgical removal of the tumor.

Goals:

• Remove as much tumor as possible

• Relieve pressure in the brain

• Obtain tissue for diagnosis

Complete resection improves survival chances.

2. Radiation Therapy

Radiation is commonly used after surgery, especially in children over 3 years old.

Types include:

• Craniospinal irradiation (CSI)

• Boost radiation to tumor bed

Radiation helps eliminate remaining cancer cells.

3. Chemotherapy

Chemotherapy is used:

• After surgery

• Along with radiation

• In infants to delay radiation

Common drugs include:

• Cisplatin

• Vincristine

• Cyclophosphamide

• Carboplatin

Chemotherapy improves long-term survival but may have side effects.

4. Targeted Therapy

In SHH subgroup tumors, targeted drugs that block specific molecular pathways are being studied.

5. Clinical Trials

Many patients benefit from enrollment in clinical trials exploring:

• Reduced radiation doses

• Immunotherapy

• Precision medicine approaches

~Side Effects of Treatment

Because treatment affects the developing brain, long-term effects are common:

Short-Term Effects

• Hair loss

• Fatigue

• Nausea

• Increased infection risk

Long-Term Effects

• Learning difficulties

• Memory problems

• Hormonal imbalance

• Hearing loss

• Growth issues

• Emotional challenges

Regular follow-up care is essential.

~Survival Rates for Medulloblastoma

Survival depends on age, molecular subtype, and spread.

5-Year Survival Rates:

• Standard-risk children: 70%–85%

• WNT subgroup: Over 90%

• High-risk cases: 50%–70%

• Adults: 60%–80%

Advancements in treatment have significantly improved outcomes compared to previous decades.

~Prognosis Factors

Better prognosis is associated with:

• Complete tumor removal

• No metastasis

• WNT molecular subtype

• Older age at diagnosis

• Early detection

Poor prognosis factors include:

• Group 3 subtype

• Metastatic disease

• Residual tumor after surgery

~Can Medulloblastoma Be Prevented?

There is currently no known way to prevent medulloblastoma. However:

• Genetic counseling may help families with inherited syndromes.

• Early evaluation of persistent neurological symptoms is crucial.

~Medulloblastoma in Adults

Although rare, adult medulloblastoma does occur.

Differences include:

• More common SHH subtype

• Better tolerance to radiation

• Slightly different chemotherapy regimens

Treatment principles remain similar to pediatric cases.

~Recurrence of Medulloblastoma

Unfortunately, recurrence can occur, especially in high-risk cases.

Common recurrence locations:

• Tumor bed

• Spinal cord

• Brain lining

Treatment options for recurrence may include:

• Additional chemotherapy

• Re-irradiation

• Clinical trials

• Stem cell transplant (in select cases)

~Living After Medulloblastoma

Survivorship care focuses on:

• Neurocognitive rehabilitation

• Physical therapy

• Endocrine management

• Psychological support

• Educational assistance

Multidisciplinary follow-up care is essential for improving quality of life.

~Frequently Asked Questions (FAQs)

Is medulloblastoma curable?

Yes, many children with standard-risk medulloblastoma can be cured with modern treatment.

Is medulloblastoma hereditary?

Most cases are not inherited, but some genetic syndromes increase risk.

How fast does medulloblastoma grow?

It is a fast-growing, aggressive tumor that requires urgent treatment.

Can adults get medulloblastoma?

Yes, but it is rare.

~Latest Research and Future Directions

Emerging research focuses on:

• Molecular-targeted therapies

• Reduced radiation protocols

• Immunotherapy

• Genetic profiling

• Personalized treatment plans

The goal is to improve survival while reducing long-term side effects.

~Conclusion

Medulloblastoma is a serious and aggressive brain tumor primarily affecting children, but significant advances in surgery, radiation therapy, chemotherapy, and molecular research have dramatically improved survival outcomes.

Early recognition of symptoms such as persistent headaches, balance problems, and vomiting is critical. Multimodal treatment strategies tailored to molecular subtype now offer hope for higher survival rates and better quality of life.

Ongoing research continues to refine therapies and reduce treatment-related complications, making the future increasingly promising for patients diagnosed with medulloblastoma.